Targeting the tumor vascular supply with vascular disrupting agents

by Soo, R.A.
Published 2014

Non-small cell lung cancer presenting with neoplastic fever at diagnosis and relapse

by Zee, Y.K., Soo, R.A.
Published 2014

Systemic therapies for pancreatic cancer - the role of pharmacogenetics

by Soo, R.A., Yong, W.-P., Innocenti, F.
Published 2014

Rare subtypes of adenocarcinoma of the lung

by Ou, S.-H.I., Kawaguchi, T., Soo, R.A., Kitaichi, M.
Published 2014

A meta-analysis on immune checkpoint inhibitor efficacy for advanced non-small cell lung cancer between East Asians versus non-East Asians

by Peng, S., Ying, A.F., Tai, B.C., Soo, R.A.
Published 2021

Lung cancer response to gefitinib, then erlotinib, then gefitinib again

by Wong, A.S., Seto, K.-Y., Chin, T.-M., Soo, R.A.
Published 2014

ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway

by Ou, S.-H.I., Tan, J., Yen, Y., Soo, R.A.
Published 2014

Clinical pharmacology and pharmacogenetics of gemcitabine

by Wong, A., Soo, R.A., Yong, W.-P., Innocenti, F.
Published 2014

Modelling and estimating dynamics of tumor shrinkage with Blenx and KinferX

by Lecca, P., Kahramanoǧullari, O., Morpurgo, D., Priami, C., Soo, R.A.
Published 2014

Poster: Modelling the tumor shrinkage pharmacodynamics with BlenX

by Lecca, P., Kahramanogullari, O., Morpurgo, D., Priami, C., Soo, R.A.
Published 2014

Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer

by Chin, L.P., Soo, R.A., Soong, R., Ou, S.-H.I.
Published 2014

Will the requirement by the US FDA to simultaneously co-develop companion diagnostics (CDx) delay the approval of receptor tyrosine kinase inhibitors for RTK-rearranged (ROS1-, RET...

by Ou, S.-H.I, Soo, R.A, Kubo, A, Kawaguchi, T, Ahn, M.-J
Published 2020

The role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancer

by Cho, B.C., Kim, J.H., Soo, R.A., Yang, C.-H.
Published 2014

Targeted therapy at the end of life for patients with lung cancer

by Wong, A.S., Teo, C., Lim, S.-W., Wong, E., Soo, R.A., Chan, N.
Published 2014

Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma

by Lim, S.M., Kim, H.R., Shim, H.S., Soo, R.A., Cho, B.C.
Published 2014

How many adenocarcinoma lung cancers come from bronchioloalveolar carcinoma?

by Wong, A.S., Seto, K.-Y., Ang, B., Wong, E., Chin, T.-M., Nga, M.-E., Soo, R.A.
Published 2014

Rapid determination of gemcitabine and its metabolite in human plasma by LC-MSMS through micro protein precipitation with minimum matrix effect

by Wang, L.-Z., Yong, W.-P., Soo, R.-A., Lee, S.-C., Soong, R., Lee, H.-S., Goh, B.-C.
Published 2014

Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression

by Soo, R., Goh, B.-C., Putti, T., Lee, K.-H., Kwok-Seng, L., Tan, L., Tao, Q., Hsieh, W.-S.
Published 2012

Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore

by Yap, H.-L., Chieng, W.-S., Lim, J.R.-C., Lim, R.S.-C., Soo, R., Guo, J., Lee, S.-C.
Published 2014

Prognostic significance of immune cells in non-small cell lung cancer: Meta-analysis

by Soo, R.A, Chen, Z, Yan Teng, R.S, Tan, H.-L, Iacopetta, B, Tai, B.C, Soong, R
Published 2020